Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript October 31, 2024 Vir Biotechnology, Inc. misses on earnings expectations. Reported EPS is $-1.56 EPS, expectations were $-0.96. Operator: [Call starts abruptly] …Vir’s Third Quarter 2024 …